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Background: Body mass index (BMI) (kg/m2) is used internationally to assess body mass or adiposity. However, BMI
does not discriminate body fat content or distribution and may vary among ethnicities. Many women with normal
BMI are considered healthy, but may have an unidentified “hidden fat” profile associated with higher metabolic
disease risk. If only BMI is used to indicate healthy body size, it may fail to predict underlying risks of diseases of
lifestyle among population subgroups with normal BMI and different adiposity levels or distributions. Higher body
fat levels are often attributed to excessive dietary intake and/or inadequate physical activity. These environmental
influences regulate genes and proteins that alter energy expenditure/storage. Micro ribonucleic acid (miRNAs) can
influence these genes and proteins, are sensitive to diet and exercise and may influence the varied metabolic
responses observed between individuals. The study aims are to investigate associations between different body fat
profiles and metabolic disease risk; dietary and physical activity patterns as predictors of body fat profiles; and
whether these risk factors are associated with the expression of microRNAs related to energy expenditure or fat
storage in young New Zealand women. Given the rising prevalence of obesity globally, this research will address a
unique gap of knowledge in obesity research.
Methods/Design: A cross-sectional design to investigate 675 NZ European, Māori, and Pacific women aged 16–45
years. Women are classified into three main body fat profiles (n = 225 per ethnicity; n = 75 per body fat profile): 1)
normal BMI, normal body fat percentage (BF%); 2) normal BMI, high BF%; 3) high BMI, high BF%. Regional body
composition, biomarkers of metabolic disease risk (i.e. fasting insulin, glucose, HbA1c, lipids), inflammation (i.e. IL-6,
TNF-alpha, hs-CRP), associations between lifestyle factors (i.e. dietary intake, physical activity, taste perceptions) and
microRNA expression will be investigated.
Discussion: This research targets post-menarcheal, premenopausal women, potentially exhibiting lifestyle
behaviours resulting in excess body fat affecting metabolic health. These behaviours may be characterised by
specific patterns of microRNA expression that will be explored in terms of tailored solutions specific to body fat
profile groups and ethnicities.
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Obesity has been described as an excess accumulation and
storage of fat in the body, typically due to an increase in
size and/or number of fat cells. Excess adiposity is generally
accepted as an important risk factor for a range of non-
communicable diseases; increased fat in the abdominal
area compared with fat around the hips poses greater car-
diovascular risks and metabolic dysregulation (Huxley
et al. 2010; Martinez et al. 2008; Cameron et al. 2009). Yet,
there has been no agreement on defining obesity in terms
of body fat percentage (BF%) (Oliveros et al. 2014). A wide
variety of BF% cut-off points have been used, varying be-
tween 20 to 25% for men and 30 to 37% for women
(Oliveros et al. 2014). Alternatively, body mass index
(BMI) is used worldwide to assess underweight, normal
weight, overweight and obesity in adults of both genders
(World Health Organisation 2011; Huxley et al. 2010;
Gallagher et al. 1996; World Health Organisation 2000).
However, BMI does not take into account body fat content
or the differential health risks associated with abdominal
(central) versus hip (peripheral) fat (Dulloo et al. 2010).
There are also concerns regarding the acceptability of BMI
as a reference value in varying ethnicities, as overweight
and obesity have been defined based on European popula-
tion data (Deurenberg 2001; World Health Organisation
2011, World Health Organisation 2000). Pacific people,
Māori and Asian communities traditionally have larger and
smaller body frames, respectively (Swinburn et al. 2004;
Huxley et al. 2010; Deurenberg 2001; Rush et al. 2009;
Ministry of Health NZ 2009) and subcutaneous fat patterns
vary among ethnicities (Deurenberg and Deurenberg-Yap
2003; Okorodudu et al. 2010). Therefore, BMI is unlikely
to accurately predict related disease risk profiles among
different population subgroups with normal BMI or those
that may have different levels of adiposity with a similar
BMI (Gallagher et al. 1996; Deurenberg 2001; Ministry of
Health NZ 2009).
Adiposity is likely to be overestimated in people with high
BMI that have higher lean body mass (e.g. athletes), whilst
underestimation is likely in those with lower BMI and less
lean body mass (Oliveros et al. 2014; Romero-Corral et al.
2010; Okorodudu et al. 2010). The concept of metabolically
obese normal weight individuals has been previously de-
scribed (Karelis et al. 2004; De Lorenzo et al. 2006), and is
associated with increased metabolic dysregulation. This has
been referred to as “Normal Weight Obesity” (De Lorenzo
et al. 2006) or as will be used in this study, a hidden body
fat profile. However, not all individuals with the “hidden
fat” profile may be at risk of metabolic disease, and it is un-
clear from previous studies whether metabolic dysregula-
tion can be explained by high total fat mass, high BF% or
high visceral fat (Oliveros et al. 2014).
During the transition from adolescence to adulthood
(15–35 years), women experience larger weight gain thanmen (Jasik and Lustig 2008). Younger women often prac-
tice risky eating (e.g. dieting, fast foods) or lifestyle (e.g.
physical inactivity) behaviours and work and environmen-
tal pressures may lead to altered food habits resulting in
higher BF% that may negatively affect their metabolic pro-
files (Haslam and James 2005; Keskitalo et al. 2008). Fur-
thermore, different taste sensitivities have been shown to
influence dietary habits and metabolic health. A higher
preference for sweet taste is associated with increased sug-
ary food consumption (Drewnowski et al. 2012), whilst
those who are hypersensitive to fatty acids consume less
total fat (Stewart et al. 2010). Specific taste perception pro-
files may therefore lead to increased adiposity and ultim-
ately reduced metabolic and cardiovascular health
(Mendoza et al. 2007; Duffey and Popkin 2008). Gene-
environment interactions may also increase the susceptibil-
ity of overweight individuals to develop hyperlipidemia,
hypertension or diabetes (Martinez et al. 2008; Arkadianos
et al. 2007). Excess body fat accumulation is mostly the re-
sult of a polygenic syndrome interacting with both dietary
and physical activity components of lifestyle (Martinez
et al. 2008). The signals delivered by food intake and phys-
ical activity regulate genes and proteins that alter energy
expenditure/storage (Buttriss 2006). Gene/protein re-
sponses to food intake and physical activity vary between
individuals; however, the cause is unknown (Martinez et al.
2008). MiRNAs are recently discovered molecules that act
as “switches” to “turn on” or “turn off” genes and proteins.
They are sensitive to diet and exercise (Güller and Russell
2010) and may influence the varied metabolic response
seen between individuals (Davidsen et al. 2011). Recently,
specific miRNAs have been suggested as biomarkers for
metabolic disease (Heneghan et al. 2011). This unique
gene-diet-physical activity relationship might impact on
the development of hidden or apparent body fat, with dif-
ferent consequences across ethnic groups and thus requires
further investigation (Swinburn et al. 2004; Arkadianos
et al. 2007; Deurenberg and Deurenberg-Yap 2003; Di
Renzo et al. 2007).
This study will be conducted as a cross-sectional com-
parative designed study. The primary aim of this study is
to explore the metabolic risks and predictive factors as-
sociated with the hidden and apparent body fat profiles
in 16 to 45 year old (post-menarcheal and premeno-
pausal) NZ European, Māori and Pacific women. The
primary outcomes are:
 Investigating the association between body
composition profiles and markers of metabolic
disease risk, including glucose, lipid and
inflammatory marker profiles;
 Investigating dietary and physical activity patterns as
predictive factors associated with body composition
profiles;
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expenditure/storage as a predictive factor associated
with body composition profiles.
The secondary outcomes are:
 Investigating associations/interactions between
dietary and physical activity patterns and miRNA
expression and how this may modulate the odds of
having a specific body composition profile;
 Investigating taste perceptions as a predictive factor
associated with the different body composition
profiles;
 Investigating eating behaviour and habits as
predictive factors associated with the different body
composition profiles;
 Investigating nutrient intake as a predictive factor
associated with the different body composition
profiles.
We hypothesise that the “hidden fat” profile is asso-
ciated with increased metabolic disease risk in NZ
European, Māori, and Pacific women aged 16 to 45 years.
We further hypothesise that for all women, dietary and
physical activity patterns are predictors of a particular
body composition profile by modulating miRNAs associ-
ated with energy expenditure/storage.
Methods/Design
Study design
The Women’s EXPLORE (“EXamining Predictors Link-
ing Obesity Related Elements”) is a cross-sectional study
targeting post-menarcheal, premenopausal NZ women
to examine predictors of body composition profiles.
Three body composition profile groups will be explored,
namely:
“Normal Fat” group – normal BMI (<25 kg/m2), nor-
mal BF% (≥22%,<30%);
“Hidden Fat” profile group – normal BMI (<25 kg/m2),
high BF% (≥30%);
“Apparent Fat” profile group – high BMI (≥25 kg/m2),
high BF% (≥30%) (Oliveros et al. 2014; Okorodudu et al.
2010; NHLBI Obesity Education Initiative Expert Panel
on the Identification Evaluation and Treatment of Over-
weight and Obesity in Adults 1998).
Participants and sample size
Study participants are adult NZ women from three eth-
nic groups (NZ European, Māori, and Pacific Island). A
total sample size of 225 women per ethnic group, con-
sisting of 75 per profile group, will provide 80% power at
significance levels of p < 0.05 to detect a medium effect
size f of 0.25 (G*Power 3.1.2) for comparing the “hidden
fat” profile with the other two body composition profiles(“normal fat” and “apparent fat”) regarding metabolic
disease risk markers, dietary and physical activity pat-
terns, and miRNA expression levels.
The medium effect size is relevant to all variables, and en-
compasses a variety of scenarios, as we wish to be able to
explore how metabolic profile changes with body compos-
ition. For example, if the three groups have equally spaced
means (μ - Δ, μ, μ +Δ), the difference in means will be de-
tected with 80% power when Δ = 0.31 x σ, where σ is the
within group standard deviation. For cholesterol, where
preliminary data suggests σ = 0.98 mmol/L, we have 80%
power to detect the difference when Δ = 0.30 mmol/L. Al-
ternately, if two groups have the same mean μ and the third
has mean μ +Δ, 80% power is achieved when Δ > 0.53 x σ,
or 0.52 mmol/L in the case of cholesterol. A Δ = 0.30 –
0.52 mmol/L is estimated to be associated with a 9 – 15%
lower relative risk of coronary heart disease (CHD)-related
mortality (Gould et al. 2007). For HDL-C where prelimin-
ary data suggests σ = 0.38 mmol/L we have 80% power to
detect a difference when Δ = 0.12 – 0.20 mmol/L. Every
0.1 mmol/L increase in HDL-C has been suggested to re-
duce CHD risk by between 8 – 15% (Gordon et al. 1989;
Turner et al. 1998). For TG where preliminary data sug-
gests σ= 0.45 mmol/L we have 80% power to detect a dif-
ference when Δ = 0.14 – 0.24 mmol/L. Studies in women
showed a 1 mmol/L increase in TG was associated with
37% increase in risk of CVD (after adjustment for HDL-C
and other risk factors)(Austin et al. 1998); Δ of 0.14 – 0.24
is thus estimated to be associated with 5.2 – 9% difference
in CVD risk.
The power for simple (one variable) logistic regression
for the risk of having a “hidden fat” profile among people
of normal BMI is equivalent to the power of the independ-
ent sample t-test (Vaeth and Skovlund 2004) for comparing
the predictor variable mean between the hidden fat and
normal fat profiles. With a sample size of 75 per group and
equal variance within groups, 80% power is achieved for
differences of 0.46 σ. For instance, preliminary data on
total energy expenditure assessed using the Recent Physical
Activity Questionnaire (RPAQ) estimates the standard de-
viation at 5.36 METs-h/day; if the true difference means
between the body composition groups is 2.47 METs-h/day,
the logistic regression coefficient will be significantly non-
zero 80% of the time. Clinically, the difference of 2.47
METs-h/day equates to ~684 kJ/day (164 kcal/day)(Besson
et al. 2010), which is considered within the target range of
recommended energy expended each day in physical activ-
ity and/or exercise (Pescatello and American College of
Sports Medicine 2014). We will consider logistic regression
predictors from the dietary and activity pattern data, and
separately for the miRNA measurements.
Based on our pilot study that showed a prevalence of
21% of NZ European women having a “hidden fat” profile,
(Kruger et al. 2010b) a sample of ~1140 women will need
Kruger et al. SpringerPlus  (2015) 4:128 Page 4 of 11to be screened (380 per ethnicity) to find ~75 women per
profile group; or to explore new profiles. The study design
and study procedures are illustrated in Figure 1.
Inclusion criteria for women are:
 age (16 to 45 years),
 being post-menarcheal or pre-menopausal (as de-
fined by a continuous regular menstrual cycle for
the past one complete year),Figure 1 Study design and procedures. ethnicity (being of NZ European, Māori, or Pacific
ethnicity as defined by self-identification and having
at least one parent from the same ethnicity).
Exclusion criteria for women are:
 pregnancy and lactation,
 presence of any diagnosed chronic illness
particularly affecting metabolic health (e.g. T2DM),
Kruger et al. SpringerPlus  (2015) 4:128 Page 5 of 11 presence of dairy allergy as the taste solution is dairy
based.
Setting and recruitment
Women are recruited in Auckland, NZ using media articles
and advertising (e.g. in newspapers, magazines, on websites
and radio interviews). Posters and flyers are used in a var-
iety of venues including local crèches, primary schools, sec-
ondary schools, local businesses and events (e.g. gym’s,
libraries, and sport events). The study is also advertised
using social media (e.g. Facebook, twitter) and via emailing
lists (e.g. Massey University staff, student, and previous re-
search participant databases). Potential participants are di-
rected to a study website for further information and to
register their interest in the study. For the Māori and Pacific
cohorts, recruitment strategies were adapted to be cultur-
ally appropriate. A more personal approach with face-to-
face contact by community liaisons, were used to recruit
women. Screening (see Stage 1 under procedures) was con-
ducted within the respective communities and special as-
sistance was provided for participants to travel to Massey
University for further data collection (Stage 2).
Procedures
The study follows a three-staged approach that involves
screening (Stage 1), on-site assessments (Stage 2), and
at-home assessments (Stage 3) (Figure 1).
Screening (stage 1)
Women who register interest are provided with an informa-
tion sheet and asked to complete a consent form and the
screening questionnaire. If all the inclusion and exclusion
criteria assessed using the screening questionnaire is met,
BMI (calculated using height and weight) and BF% (assessed
using bioelectrical impedance (BIA)) are used for prelimin-
ary categorisation into the body composition profile groups
(described above). The body composition screening is done
in person and either at the Human Nutrition Research Unit,
Albany campus, Massey University, or off-site.
Assessments (stages 2 and 3)
Participants recruited in stage 1 are invited to the re-
search unit within 14 days of the start of their last men-
strual period (the follicular phase) for testing to avoid
the confounding effect of menstrual cycle hormones on
taste perception, energy intake and energy expenditure
(Davidsen et al. 2007).
Stage 2 of testing involves measurements of anthro-
pometry, body composition, metabolic health, dietary in-
take, taste perception, and eating behaviour, which are
described in detail below.
Stage 3 of assessment is completed at home over a seven
day period. Participants wear accelerometers and keep a
physical activity diary to assess physical and sedentaryactivity objectively in real life. At the end of the seven days,
participants complete the RPAQ and the dietary diversity
questionnaire (DDQ) (see Figure 1).
Measures
The chosen measures and/or methods used for the various
assessments in stages 1, 2 and 3 are listed in Table 1.
Body composition assessment
Anthropometric measurements include weight, height,
waist and hip circumferences using the International So-
ciety for the Advancement of Kinanthropometry (ISAK)
protocol (Marfell-Jones et al. 2006). Waist-to-hip ratio,
waist-to-height ratio and BMI will be derived from these
measures and will be used to assess body composition in
terms of obesity along with associated disease risk
(NHLBI Obesity Education Initiative Expert Panel on
the Identification Evaluation and Treatment of Over-
weight and Obesity in Adults 1998). Fat and lean mass
are assessed using BIA (Boneva-Asiova and Boyanov
2008; Ling et al. 2011) for screening and preliminary cat-
egorisation into profile groups, and air displacement
plethysmography (ADP) (using thoracic gas volume
method) for final categorisation (Wingfield et al. 2014;
Noreen and Lemon 2006), as well as DXA measure-
ments for regional body composition (Boneva-Asiova
and Boyanov 2008).
Metabolic health assessment
After an overnight fast (no food or beverages, excluding
water for 12 hours prior to phlebotomy), blood samples
are obtained by registered phlebotomists between 7.00
and 10.00 am and prior to sensory testing. Serum and
plasma samples (ethylene diamine tetraacetic acid
(EDTA) and heparin) are collected and processed in ac-
cordance with pathology laboratory protocols. All sam-
ples are frozen in separate aliquots in Eppendorf tubes
and stored at −80°C until analysis. Analysis will be car-
ried out by a fully accredited (with IANZ to the ISO
15189) laboratory or by qualified laboratory technicians
upon completion of data collection. Biomarkers that will
be analysed include plasma levels of glucose, total chol-
esterol, triglycerides, HDL-C, LDL-C, insulin, leptin,
serum hs-CRP, Il-6 and TNF-alpha using commercially
available kits or using routine enzymatic assays as pub-
lished by our team (van Langenberg et al. 2014; Smith
et al. 2012). The analyses will be performed using either
a Biotek Synergy 2 Plate Reader (Millennium Science,
Balwyn, Vic) or a Bioplex 200 plate reader (BioRad
Hercules CA) depending on the required assay.
Selected miRNA species to assess metabolic disease risk
and to explore energy expenditure and storage will be mea-
sured as published by our group (Russell et al. 2012; Güller
and Russell 2010; Russell et al. 2013; Zacharewicz et al.
Table 1 Measures and methods
Domain Measures / methods Reference Equipment Concept captured
Body composition: anthropometry. Anthropometric measurements
(height, weight, circumferences)
using ISAK protocol and standards.
(NHLBI Obesity Education Initiative
Expert Panel on the Identification
Evaluation and Treatment of
Overweight and Obesity
in Adults 1998)
Stadiometer, Lufkin tape. Body composition.
- Profile in terms of BMI (weight,
height)
- Risk in terms of circumferences
and ratios (waist, hip, height).
Body composition profile – fat and
lean mass.
- (Ling et al. 2011) Bioelectrical Impedance (BIA) (InBody230,
Biospace Co. Ltd, Seoul).
Body composition - (fat and lean
mass).
- total
- (Noreen and Lemon 2006; Wingfield
et al. 2014)
Air displacement Plethysmography (BodPod)
(2007A, Life Measurement Inc, Concord, Ca.,
using software V4.2+ as supplied by the
manufacturer).
Body composition - (fat and lean
mass).
- total
- (Boneva-Asiova and Boyanov 2008) Dual XRay Absorptiometry (DXA) (Hologic
QDR Discovery A, Hologic Inc, Bedford, MA.
with APEX V. 3.2 software.
Body composition - (fat and lean
mass).
- total
- regional
Metabolic health – biomarkers. Analysis will be conducted by fully
accredited laboratory with IANZ to
the ISO 15189.
- Blood sampling to capture plasma glucose,
total cholesterol, triacylglyceride, HDL-
cholesterol, LDL-cholesterol, insulin, serum
hs-CRP, Il6, TNF-alpha, HbA1C, Leptin, Ghrelin.
Biomarkers related to metabolic
health (lipid profile, glucose control,
inflammation, hormonal control).
Metabolic health – blood pressure. - (Ogedegbe and Pickering 2010) Blood pressure measurement Riester Ri-Chamion
N digital blood pressure monitor, using one of
two arm cuff sizes (22-32 cm or 32-48 cm).
Blood pressure related to metabolic
health.
Metabolic health – gene expression - (Russell et al. 2012; Zacharewicz
et al. 2014 )
miRNA - use specific primer and probes
sets as per the manufacturer’s instructions
(Applied Biosystems, Carlsbad, USA) using an
MX3000p thermal cycler system.
miRNA species will be measured using
published techniques.
MiRNA related to energy
expenditure.
Diet Quality Food Frequency Questionnaire
(FFQ)
(Ministry of Health NZ 1997;
McNaughton 2011; Mishra
et al. 2010)
Analysis using Foodworks7 2010 (Xyris Software
(Australia) Pty Ltd, Queensland, Australia).
Dietary adequacy
- energy intake
- nutrient intake
Patterns of food and nutrient
intake.
Diet Quality Eating Habits Questionnaire Developed in this study - Dietary habits
- eating habits
- meal distribution
- food choices.
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Table 1 Measures and methods (Continued)
Dietary Variety Dietary Diversity Questionnaire
(DDQ)
Developed in this study; mostly
based on foods in the FFQ
- Dietary diversity
Food variety.
Dietary Behaviour Three Factor Eating Questionnaire
(TFEQ)
(Stunkard and Messick 1985) - Dietary behaviour
- Restraint,
- Disinhibition,
- Hunger.
Physical Activity patterns - (Pescatello and American College
of Sports Medicine 2014)
WGT3X Actigraph Objective real life physical activity
Physical activity expenditure
- sedentary activities
- intensity of activity.
Physical Activity diary - - Self-reported accelerometer non-
wear time
Self-reported intentional exercise
– time
- duration
- type
- intensity.
Physical Activity behaviour Recent Physical Activity
Questionnaire (RPAQ)
(Besson et al. 2010) - Self-reported physical activities
- sedentary activities
- time
- intensity.
Taste perception, intensity,
and hedonic preference
- (Lim et al. 2008; Bartoshuk
et al. 2004)
Rate intensity and hedonic preference
of sweet and fat taste on a gLMS.
Sweet and fat taste sensitivity and
preference.
Kruger
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transcribed using target specific primers followed by qPCR
using target specific probes as published routinely by our
group. All qPCR analysis will be performed using the
Stratagene MX3000p thermocycler (Stratagene, La Jolla,
CA); miRNA results will be normalized to RNA input and
log transformed if not normally distributed.
Resting blood pressure measurements are taken whilst
sitting, following a 10 minute resting period after taste per-
ception assessments. For blood pressure measurements, an
arm cuff is attached to the arm that has not been used for
the venepuncture and three measurements are taken con-
secutively in one minute intervals (Ogedegbe and Pickering
2010).
Dietary intake data
A 220-item self-administered semi-quantitative food fre-
quency questionnaire (FFQ) is used. The FFQ was adapted
from the validated FFQ used in the Adult National Nutri-
tion survey in NZ (Ministry of Health NZ 1997). Changes
include an expanded food list to include currently con-
sumed/available foods, additional questions relating specif-
ically to fast food and snack food intakes, changes to the
order of questions to improve continuity between ques-
tions. The food intake data will be processed using the
Foodworks7 (Xyris Software (Australia) Pty Ltd, Queens-
land, Australia) dietary analysis database utilising FOOD-
files 2010 (developed by the NZ Institute for Plant & Food
Research and the NZ Ministry of Health) as the reference
food composition table for NZ. Dietary quality and variety
of the whole diet will be assessed, including nutritional ad-
equacy and usual intake patterns and adherence to NZ
dietary guidelines (Wirt and Collins 2009; Kant and
Graubard 2005; Ibiebele et al. 2009). The frequency and
patterns of intake of various nutrient-rich/poor dietary
components and dietary factors that may affect fat depos-
ition/obesity (e.g. sugar/fat-rich foods, fast foods, etc.) and
related habits will be investigated. Foods from the FFQ will
be grouped accordingly and factor analysis will be used to
determine dietary pattern scores (McNaughton 2011;
Mishra et al. 2010). Dietary variety will be assessed using
dietary diversity scores and food variety scores to explore
the variety of nutritious and non-nutritious foods (Ruel
2003; Murphy et al. 2006). Eating habits, meal patterns and
food choices are explored using a self-developed and vali-
dated (during the current study) questionnaire, providing
descriptive data of the women’s dietary practices.
Dietary behaviour is assessed using the validated
TFEQ (Stunkard and Messick 1985; Bond et al. 2001) to
measure three eating behaviour traits. The three factors
are cognitive dietary restraint (Restraint), disinhibition of
control (Disinhibition) and susceptibility to hunger
(Hunger) by calculating scores for the dimensions and
their sub-categories.Sensory testing
Sensitivity and preferences of sweet and fat taste are
assessed. Participants rate the intensity and hedonic
preference of five sucrose and dairy samples on a general
labelled magnitude scale (gLMS) (Bartoshuk et al. 2004;
Lim et al. 2008).
Physical activity
A w-GT3X triaxial accelerometer (Actigraph, Pensacola,
FL) secured to a waist belt, is worn for seven days, with
a minimum of 10 h per day, to measure all components
of physical activity and energy expenditure. Participants
maintain their regular physical activity, whilst keeping a
diary of times when the device is not worn. At least
three full week and two weekend days is required for
analysis. Physical activity counts will be calculated from
raw data as the square root of the sum squared of activ-
ity counts, and will be categorized using metabolic
equivalents (METs), as defined by the American College
of Sports Medicine guidelines (Pescatello and American
College of Sports Medicine 2014). Activities will be clas-
sified as light or sedentary (1.1-2.9 METs), moderate
(3.0-6.0 METs), or vigorous (>6.0 METs). A physical ac-
tivity diary is kept to record periods of non-wear and of
intentional exercise. A self-reported RPAQ (Besson et al.
2010) is completed at the end of seven days with refer-
ence to the previous four weeks, allowing, together with
the diary, a specific interpretation of the accelerometry
counts.
Data handling and statistical analysis
Statistical analysis will be performed using IBM SPSS
statistics (IBM Corporation, New York, USA). Descrip-
tive statistics will be used to describe the baseline popu-
lation using mean (standard deviation), median (25, 75
percentile) or frequencies summary statistics. Normality
of distribution will be evaluated using the Kolmogorov-
Smirnov test and examining normality plots. Non-
normally distributed variables will be transformed into
approximately normal distributions by logarithmic trans-
formations and again tested for normality. Primary stat-
istical analyses will involve ANOVA tests with post-hoc
analysis and Bonferoni adjustments comparing body
composition profile groups regarding metabolic disease
risk markers and dietary and physical activity patterns
and miRNA levels; multiple logistic regression analysis
to determine odds ratios of having a “hidden body fat”
profile based on dietary and physical activity patterns;
and, separately, miRNA expression levels. Principal com-
ponents analysis will be performed on the miRNA data
using the PCP directive in GenStat to identify linear
combinations of the miRNAs that account for most of
the variation between individuals (Zacharewicz et al.
2014); and Pearson correlations to determine correlation
Kruger et al. SpringerPlus  (2015) 4:128 Page 9 of 11coefficients between dietary and physical activity pat-
terns and miRNA expression profiles. A p-value of <0.05
will be considered significant.Ethics
Ethical approval was obtained from the Massey Univer-
sity Human Ethics Committee: (Southern A), Reference
No.13/13.Discussion
An ethnic-specific focus aimed at weight maintenance has
been recommended from previous NZ research (Metcalf
et al. 2000). Overweight or obesity is a continual process
and the effects of inappropriate lifestyle behaviour may
often be missed when strictly assessing BMI as an indicator
of over-nutrition. BMI provides only a crude measure of
body fatness as it does not distinguish between weight as-
sociated with muscle or with fat. However, it appears to re-
main a useful estimate of the proportion of the population
with increased risk of health conditions associated with
obesity (World Health Organisation 2000), but may not be
able to predict disease risk in those with normal BMI and
varying adiposity.
Previous research has shown that a significant propor-
tion of individuals with normal weight and subsequent
normal BMI values had excessive body fat or “hidden” fat
(Kruger et al. 2010a; De Lorenzo et al. 2006; Romero-
Corral et al. 2010; Kruger et al. 2010b). This “hidden fat”
profile may be linked with early inflammation and may be
a key factor in the emerging epidemic of obesity and re-
lated disease risk (De Lorenzo et al. 2006; De Lorenzo et al.
2007). Pilot study data from our laboratory (Kruger et al.
2010a; Kruger et al. 2010b) revealed that in a free-living
population (N= 116) of 18 to 44 year old NZ European
women, 21.4% had a “hidden fat” profile and subsequent
increased metabolic disease risk (identified through ele-
vated fasting plasma leptin and insulin concentrations) and
higher levels of sedentary lifestyle parameters.
Although a few studies have explored normal weight
obesity (Marques-Vidal et al. 2008; Di Renzo et al. 2010;
Romero-Corral et al. 2010; Karelis et al. 2004), not many
studies have been specifically conducted to explore meta-
bolic disease risk associated with high body fat (hidden or
apparent), in premenopausal women. The typical central
fat deposition following menopause and/or ageing may be
absent in premenopausal women, despite the fact that
women steadily gain weight from menarche to adulthood.
It is therefore unclear where the hidden fat is situated in
these women, especially if they are slender. It may be that
excess fat in a lean person is hidden in the abdomen or
elsewhere where it could pose health risks and cause meta-
bolic dysregulation (Di Renzo et al. 2006; Huxley et al.
2010; Martinez et al. 2008; Cameron et al. 2009).Implications
The presence of normal weight obesity varies between 2 to
28% in women (Oliveros et al. 2014). The origins are un-
clear and may be due to environmental as well as genetic
factors (Oliveros et al. 2014; Karelis et al. 2004). Common
recommendations for appropriate dietary or lifestyle be-
haviours may be ineffective due to individual genetic vari-
ation. Dietary or physical activity behaviours may influence
molecular mechanisms controlling metabolic activity and
gene expression. MiRNAs can regulate the gene and pro-
tein networks that control substrate utilization and storage.
Differences in behaviour that impact on miRNA expression
need to be identified in different body composition profiles.
Identifying these differences may assist in developing pre-
ventive recommendations (Arkadianos et al. 2007), and
need to be specific to the locality and culture of the target
population (Swinburn et al. 2004).
Because we do not know if and where slender women of
different ethnicities with a normal BMI store hidden fat, it
is important to identify this and its possible impact on
women’s health. It is equally important to consider these
issues in women with apparent fat and normal BF% to be
able to make comparisons and explore tailored solutions.
Our study will address a unique gap in health research
knowledge by investigating multi-ethnic populations in
NZ, identifying important physiological and behavioural
predictors of metabolic disease risk. This research will as-
sist in providing an important piece of the metabolic health
versus body composition puzzle to fall into place and gen-
erate new pathways for treatment or early intervention.
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